Two Boeing directors, Mortimer Buckley and Steven Mollenkopf, purchased shares on the open market in early November 2026 as the stock traded near $172. Buckley acquired 5,820 shares at $171.55, while Mollenkopf bought 2,950 shares at $173.03, signaling a vote of conviction from the board despite the company's recent struggles and trading well below its highs. Wall Street analysts align with these insider moves, as none of the 28 analysts covering Boeing rate it a Sell. The consensus price target stands at $233.35, representing a 32% premium to the current stock price. This bullish sentiment is underpinned by a record backlog of $745 billion and management's plan to generate free cash flow of approximately $3 billion in 2027. However, significant operational headwinds remain, specifically regarding the 737 program. Boeing aims to reach a steady production rate of 47 airplanes per month but faces constraints with wing and fuselage manufacturing that have delayed deliveries. Management acknowledges the transition from lower production rates has been smoother than the current push toward the 47-unit target. The stock currently trades below its 50-day and 200-day moving averages, reflecting a forward P/E of 51 which prices in a recovery rather than current earnings. Investors are advised to monitor Boeing's program-level delivery update scheduled for January, as clear progress toward the 47-unit monthly rate is required to close the gap between the current price and analyst targets.